
NEWS
Putting the Patient First: Optimising Injectable Drug Development for Clinical Success
Jul 01, 2025
Accelerate the delivery of robust, patient-centered solutions
Every year, Jabil delivers hundreds of millions of drug delivery systems to our customers. We support top brands to design, develop, and manufacture some of the most complex and innovative drug delivery devices in the market. In addition, we offer CDMO solutions from Pii, a Jabil company, specializing in aseptic manufacturing, oral dosage forms, and accelerated drug development. Together, Jabil and Pii offer truly end-to-end pharmaceutical solutions.
Jabil and Pii are trusted by leading pharma brands for services including:
Aseptic fill/finish
Auto—injectors
Cold chain management
Connected solutions
Container-device integration
Device development services/product innovation
Dry powder inhalers (DPIs)
Final test, assembly, and pack
Insulin pens
Metered dose inhalers (MDIs)
Needle-free injection systems
On-body delivery systems (pumps)
Primary packaging
Jabil's engagement with customers begins with design and development, migrating across the entire product lifecycle: manufacturing, sterilization, and assembly of final product including the ability to integrate pre-filled drugs into primary containers’ delivery devices before they leave the factory.
To support our customers in a dynamic market that demands continuous innovation, Jabil has a proven track record of successfully executing large new product introductions (NPI) and ramping into commercial production. We simultaneously accommodate iterative process improvements to reduce risk and cost while maintaining strict quality and performance standards.
|
|
Jabil accelerates your time-to-market by reducing the number of design cycles and lowering development costs while delivering robust, patient-centered, scalable solutions. With over 3,000 engineers across various disciplines and healthcare sectors, Jabil brings unmatched breadth, depth, and expertise to your solution.
Jabil’s unparalleled access to world class suppliers of materials, tooling, processes, and automation enables you to develop robust and scalable solutions with a lower total cost of ownership. With over 38,000 vetted suppliers leveraging a $25 billion annual purchasing spend, across the multiple sectors Jabil serves, we provide access to secure supply.
Our global network offers you regional options and greater flexibility. Jabil's network of healthcare sites consists of 35 manufacturing sites in 12 countries. This allows you to align your manufacturing solutions with your business objectives and to consider cost, security of supply, market expansion, lifecycle management, and geography when planning production.
Our commitment to operational excellence, quality, and customer satisfaction sets Jabil apart. A two-time winner of the Shingo Prize, Jabil applies Lean Six Sigma methodologies to deliver the highest operational efficiency while maintaining quality standards, safety, and high performance.
Trust Jabil to enhance your sustainability performance. Jabil’s industry-leading design, global supplier network, and supply base optimization tools allow you to integrate environmentally intentional design practices to reduce your carbon footprint and amount of waste.
Simple, reusable, modular solution for subcutaneous drug self-administration
Jabil's Qfinity™ autoinjector platform is purpose-designed to accommodate the connected future of healthcare and today’s evolving drug formulations.
Available at a lower cost than market alternatives, the Qfinity platform supports the emerging prioritization of sustainable drug delivery within the pharmaceutical industry.
Trends reshaping drug portfolios:
Increasing demand for subcutaneous delivery of large volume complex biologics
Shift to more patient self-administration in the home setting
Preference for seamless, patient-centric designs and delivery systems
Leverage of next-generation technology to reduce patient burden and process timelines in clinical trials
Increasing calls to improve medical device sustainability metrics
Concerns from consumers and industry to reduce medical waste
Get started with a trusted partner.
Related Insights
NEWS
Jul 01, 2025
NEWS
Apr 04, 2025
NEWS
Apr 02, 2025
NEWS
Feb 04, 2025
INSIGHT
Jul 12, 2022
NEWS
Oct 27, 2021
INSIGHT
Oct 05, 2022
INSIGHT
Oct 01, 2021
NEWS
Jul 01, 2025
NEWS
Apr 04, 2025
NEWS
Apr 02, 2025
NEWS
Feb 04, 2025
INSIGHT
Jul 12, 2022
NEWS
Oct 27, 2021
INSIGHT
Oct 05, 2022
INSIGHT
Oct 01, 2021